Enroll the last patient in the RADIANT Phase 2 study
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 26 Feb 2025
- Due
- 31 Mar 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“the last patient is expected to be enrolled in the first quarter of 2026”
What we found
Evidence strength A What the grades mean
The company confirmed in August 2026 that it had completed enrollment in the Phase 2 portion of the RADIANT program, implying the commitment was met within the Q1 2026 timeframe.
-
A Acadia Pharmaceuticals Inc. 10-Q filed 2026-08-05
“We have completed enrollment in the Phase 2 portion of the RADIANT program” ✓ confirmed on the page
Market reaction: the shares moved +7.3% against the S&P 500 over the three sessions around the disclosure (4 Aug 2026 to 7 Aug 2026). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Enroll
- Deliverable
- RADIANT Phase 2 study enrollment
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “no_evidence”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Acadia Pharmaceuticals Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-ACAD-002593 · Corrections policy